Carotid atherosclerosis in patients with untreated chronic obstructive pulmonary disease

International Journal of Tuberculosis and Lung Disease

Volumn 15, Issue 9, 2011, Pages 1265-1270

  Kim, S J ^a   Yoon, D W ^a   Lee, E J ^b   Hur, G Y ^c   Jung, K H ^a   Lee, S Y ^b,c   Shin, C ^a   Shim, J J ^c   In, K H ^b   Kang, K H ^c   Yoo, S H ^b   Kim, Je Hyeong ^a  

^a Korea University   (South Korea)

^b College of Medicine   (South Korea)

^c Korea University College of Medicine   (South Korea)

Author keywords

C reactive protein; Cardiovascular diseases; COPD

Indexed keywords

C REACTIVE PROTEIN; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SALBUTAMOL SULFATE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; VENTOLIN EVOHALER;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HUMAN; INFLAMMATION; LUNG FUNCTION; MALE; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY AIRFLOW; SMOKING; SPIROMETRY; SYSTOLIC BLOOD PRESSURE;

AGED; C-REACTIVE PROTEIN; CAROTID ARTERIES; CAROTID ARTERY DISEASES; CASE-CONTROL STUDIES; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; TUNICA INTIMA; TUNICA MEDIA;

EID: 80051690295     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.10.0680     Document Type: Article

References (35)

1. Rabe K F, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555. (Pubitemid 47403272)
2. Gan W Q, Man S F, Senthilselvan A, et al. Association between chronic obstructive pulmonary disease and systemic infl ammation: a systematic review and a meta-analysis. Thorax 2004; 59: 574-580. (Pubitemid 38901515)
3. Eid A A, Ionescu A A, Nixon L S, et al. Infl ammatory response and body composition in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2001; 164: 1414-1418. (Pubitemid 33124019)
4. Dahl M, Vestbo J, Lange P, et al. C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175: 250-255. (Pubitemid 46203128)
5. Libby P, Ridker P M. Infl ammation and atherosclerosis: role of C-reactive protein in risk assessment. Am J Med 2004; 116 (Suppl 6A): 9S-16S.
6. Sin D D, Wu L, Man S F. The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
7. Faxon D P, Fuster V, Libby P, et al. Atherosclerotic Vascular Disease Conference: Writing Group III: pathophysiology. Circulation 2004; 109: 2617-2625. (Pubitemid 38720566)
8. Baldassarre D, Amato M, Bondioli A, et al. Carotid artery intima-media thickness measured by ultrasonography in normal clinical practice correlates well with atherosclerosis risk factors. Stroke 2000; 31: 2426-2430.
9. Ross R. Atherosclerosis-an infl ammatory disease. N Engl J Med 1999; 340: 115-126.
10. Esposito K, Giugliano D, Nappo F, et al. Regression of carotid atherosclerosis by control of postprandial hyperglycemia in type 2 diabetes mellitus. Circulation 2004; 110: 214-219. (Pubitemid 38924590)
11. Minoguchi K, Yokoe T, Tazaki T, et al. Increased carotid i ntima-media thickness and serum infl ammatory markers in obstructive sleep apnea. Am J Respir Crit Care Med 2005; 172: 625-630. (Pubitemid 41232975)
12. Roman M J, Moeller E, Davis A, et al. Preclinical carotid atherosclerosis in patients with rheumatoid arthritis. Ann Intern Med 2006; 144: 249-256. (Pubitemid 46768207)
13. Schroeder E B, Welch V L, Evans G W, et al. Impaired lung function and subclinical atherosclerosis. The ARIC Study. Atherosclerosis 2005; 180: 367-373. (Pubitemid 41072908)
14. Iwamoto H, Yokoyama A, Kitahara Y, et al. Airfl ow limitation in smokers is associated with subclinical atherosclerosis. Am J Respir Crit Care Med 2009; 179: 35-40.
15. van Gestel Y R, Flu W J, van Kuijk J P, et al. Association of COPD with carotid wall intima-media thickness in vascular surgery patients. Respir Med 2010; 104: 712-716.
16. Kim S J, Suk M H, Choi H M, et al. The local prevalence of COPD by post-bronchodilator GOLD criteria in Korea. Int J Tuberc Lung Dis 2006; 10: 1393-1398. (Pubitemid 44924595)
17. Friedewald W T, Levy R I, Fredrickson D S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
18. Standardization of spirometry, 1994 Update. American Thoracic Society. Am J Respir Crit Care Med 1995; 152: 1107-1136.
19. Touboul P J, Hennerici M G, Meairs S, et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23: 75-80.
20. O'Leary D H, Polak J F, Kronmal R A, et al. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14-22. (Pubitemid 29024679)
21. Suzuki T, Nakano H, Maekawa J, et al. Obstructive sleep apnea and carotid-artery intima-media thickness. Sleep 2004; 27: 129-133. (Pubitemid 43906324)
22. Sin D D, Anthonisen N R, Soriano J B, et al. Mortality in COPD: role of comorbidities. Eur Respir J 2006; 28: 1245-1257. (Pubitemid 44883863)
23. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993; 362: 801-809. (Pubitemid 23132154)
24. Chambless L E, Folsom A R, Davis V, et al. Risk factors for progression of common carotid atherosclerosis: the Atherosclerosis Risk in Communities Study, 1987-1998. Am J Epidemiol 2002; 155: 38-47. (Pubitemid 34042431)
25. De Pergola G, Ciccone M, Pannacciulli N, et al. Lower insulin sensitivity as an independent risk factor for carotid wall thickening in normotensive, non-diabetic, non-smoking normal weight and obese premenopausal women. Int J Obes Relat Metab Disord 2000; 24: 825-829. (Pubitemid 30449917)
26. Hodis H N, Mack W J, LaBree L, et al. Reduction in carotid arterial wall thickness using lovastatin and dietary therapy: a randomized controlled clinical trial. Ann Intern Med 1996; 124: 548-556. (Pubitemid 26085055)
27. Libby P, Ridker P M, Hansson G K. Infl ammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 2009; 54: 2129-2138.
28. Corrado E, Rizzo M, Coppola G, et al. An update on the role of markers of infl ammation in atherosclerosis. J Atheroscler Thromb 2010; 17: 1-11.
29. Pinto-Plata V M, Mullerova H, Toso J F, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006; 61: 23-28. (Pubitemid 43106973)
30. Weis N, Almdal T. C-reactive protein-can it be used as a marker of infection in patients with exacerbation of chronic obstructive pulmonary disease? Eur J Intern Med 2006; 17: 88-91. (Pubitemid 43265856)
31. Lorenz M W, Karbstein P, Markus H S, et al. High-sensitivity C-reactive protein is not associated with carotid intima-media progression: the carotid atherosclerosis progression study. Stroke 2007; 38: 1774-1779. (Pubitemid 46847246)
32. Ragino Y I, Chernjavski A M, Polonskaja Y V, et al. Blood levels of infl ammatory and destructive biomarkers in coronary atherosclerosis of different severity. Bull Exp Biol Med 2010; 149: 587-590.
33. Nurkic J, Ljuca F, Nurkic M, et al. Biomarkers of plaque instability in acute coronary syndrome patients. Med Arh 2010; 64: 103-106.
34. Shaker O G, El-Shehaby A, Nabih M. Possible role of osteoprotegerin and tumor necrosis factor-related apoptosis-inducing ligand as markers of plaque instability in coronary artery disease. Angiology 2010; 61: 756-762.
35. Futterman L G, Lemberg L. High-sensitivity C-reactive protein is the most effective prognostic measurement of acute coronary events. Am J Crit Care 2002; 11: 482-486.